Curis
CRIS
#10257
Rank
A$31.85 M
Marketcap
A$0.80
Share price
3.17%
Change (1 day)
-65.96%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): A-$5.79

According to Curis's latest financial reports the company's current EPS (TTM) is A-$5.32. In 2024 the company made an earnings per share (EPS) of A-$10.19 an increase over its 2023 EPS that were of A-$13.08.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$5.79-43.18%
2024A-$10.19-22.15%
2023A-$13.08-26.17%
2022A-$17.7222.3%
2021A-$14.49-25.37%
2020A-$19.41-30.93%
2019A-$28.11-2.02%
2018A-$28.69
2016A-$65.20-10%
2015A-$72.44138.1%
2014A-$30.4340%
2013A-$21.73-25%
2012A-$28.9866.67%
2011A-$17.39

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.97-137.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$5.01-194.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
A-$0.52-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$4.19-178.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A-$5.64 5.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
A-$16.28 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$2.04-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA